Entrada Therapeutics (TRDA) EBITDA Margin (2023 - 2026)
Entrada Therapeutics' quarterly EBITDA Margin came in at 4585.49% in Q1 2026, down 450343.0% year-on-year from N/an in Q1 2025, and down 52.21% quarter-over-quarter from 3012.55% in Q4 2025.
Entrada Therapeutics has reported EBITDA Margin for 4 years, with the latest figure at 4585.49% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 450343.0% year-over-year to 4585.49%; the trailing twelve-month figure through Mar 2026 stood at 2898.38% (down 291316.0% YoY), and the FY2025 full-year result was 562.74%, down 59377.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 4585.49%, down from 3012.55% in the prior quarter.
- The five-year high for EBITDA Margin was 82.25% in Q3 2023, with the low at 4585.49% in Q1 2026.
- Average EBITDA Margin over 4 years is 975.79%, with a median of 65.05% recorded in 2024.
- Year-over-year, EBITDA Margin jumped 20272 bps in 2024 and plunged 450343 bps in 2026.
- Tracing TRDA's EBITDA Margin over 4 years: stood at 21.16% in 2023, then surged by 101 bps to 0.31% in 2024, then tumbled by 971335 bps to 3012.55% in 2025, then plunged by 52 bps to 4585.49% in 2026.
- The last three EBITDA Margin figures came in at 4585.49% (Q1 2026), 3012.55% (Q4 2025), and 2720.76% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 18.35% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 17.24% |
| 10 | Entrada Therapeutics | 295.78 Mn | 295.78 Mn | - | -4,585.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,585.49% |
| Dec 31, 2025 | -3,012.55% |
| Sep 30, 2025 | -2,720.76% |
| Jun 30, 2025 | -2,212.31% |
| Mar 31, 2025 | -82.06% |
| Dec 31, 2024 | 0.31% |
| Sep 30, 2024 | -65.05% |
| Jun 30, 2024 | 58.03% |
| Mar 31, 2024 | 39.00% |
| Dec 31, 2023 | -21.16% |
| Sep 30, 2023 | 82.25% |
| Jun 30, 2023 | -144.69% |
| Mar 31, 2023 | -20.82% |